DXDexCom DXCM · NASDAQ
$86.04 -1.90% (-$1.67)
- Market cap
- $33.1B
- Enterprise value
- $33.4B
- P/E
- 33.1x
- Forward P/E
- 32.5x
- PEG
- 0.9x
- P/S
- 6.7x
- P/FCF
- 23.6x
- EV/EBITDA
- 21.4x
- ROIC
- 21.6%
- Gross margin
- 62.5%
- Net margin
- 20.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 0.2x
- Beta
- 1.48
- Free float
- 99.6%
About the company
DexCom, Inc. (DXCM) is an American healthcare company specializing in the development and production of continuous glucose monitoring (CGM) systems for patients with diabetes. With innovative products like the Dexcom G6, DexCom provides accurate and continuous monitoring of blood sugar levels, allowing patients and healthcare professionals to better manage diabetes and improve quality of life. The company is known for its focus on technological innovations and continuous improvement of its products. DexCom also collaborates with other healthcare companies to integrate its CGM systems into broader healthcare ecosystems. DexCom, Inc. (DXCM) shares could be suitable for investors looking for opportunities in the medical technology sector with a focus on diabetes and innovations in health monitoring.
Sector
Healthcare
Industry
Medical - Devices
CEO
Jacob Steven Leach
Employees
11,050
Headquarters
San Diego
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number